The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBluebird Mer Regulatory News (BMV)

Share Price Information for Bluebird Mer (BMV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.625
Bid: 0.60
Ask: 0.65
Change: 0.00 (0.00%)
Spread: 0.05 (8.333%)
Open: 0.625
High: 0.625
Low: 0.625
Prev. Close: 0.625
BMV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

South Korean Board Appointment

20 Jul 2022 07:00

RNS Number : 0934T
Bluebird Merchant Ventures Limited
20 July 2022
 

Bluebird Merchant Ventures Ltd

("Company" or "Bluebird")

South Korean Board Appointment

Bluebird Merchant Ventures (EPIC: BMV), the South Korean focused gold development group is pleased to announce the appointment of Mr. Sung Kwan (Daniel) Sun to the Board of Directors of the South Korean subsidiary companies. The Company considers this to be a key appointment that will strengthen the Company and its operations in South Korea. As the projects move into production there will be significantly more work taking place in country than previously and this requires experienced personnel in key positions.

Daniel Sun is a graduate of Sogang University. He worked at Deloitte Anjin LLC from 2004 to 2014. He is an advisor to the Korea Trade-Investment Promotion Agency (KONTRA) Global Mergers and Acquisitions. Daniel specialises in foreign invested Korean companies. He has successfully assisted Doosan Group, a South Korean multinational conglomerate in their overseas acquisitions of Mitsui Babcock (UK), Labmeyer (Germany) and Isola (USA). He also assisted in the management of offshore projects by Mirae Asset Real Estate Funds, Lotte Construction and Dongwon Group in the acquisition of Starkist. Daniel is also a Certified Public Accountant and a partner at Wooin Accounting Firm.

 

The Company has previously made announcements regarding the admission to trading of shares that were previously issued. After dialogue with the FCA, the Company has been able to determine a certain number of historical share issuances that require admission to trading. 

An application has been made for the Admission of the following shares to trading - 13,003,268 shares at an average of 2p ("Funding Shares"); the exercise of warrants over 2,692,307 shares at 1.3p ("Warrant Exercise Shares"); and 62,385,234 shares at an average of 2.49p ("April 2016 to March 2019 Shares"). The Company had believed that the April 2016 to March 2019 Shares had previously be admitted to trading as the Company published a Prospectus on 13 June 2019 and 20 December 2021. Admission is expected to occur on or around 21 July 2022. Upon Admission there will be 638,115,042 shares in issue.

Colin Patterson, CEO, commented:

"I am delighted to welcome Daniel to the team. I have been impressed with his professionalism and am confident that his appointment will contribute to the success of our Company. I am also expecting that we will be announcing further key appointments over time." 

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION EU 596/2014 ("MAR").

Enquiries:

Bluebird Merchant Ventures Ltd

Jonathan Morley-Kirk, Non-Executive Chairman jmk@bluebirdmv.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAMZGZNZGGGZZG
Date   Source Headline
22nd Feb 20214:41 pmRNSSecond Price Monitoring Extn
22nd Feb 20214:36 pmRNSPrice Monitoring Extension
22nd Feb 20217:00 amRNSOperational Update
27th Jan 20217:00 amRNSFurther re Joint Venture Update
30th Dec 20207:00 amRNSAGM Results
30th Nov 20207:00 amRNSJoint Venture Update
26th Nov 20204:41 pmRNSSecond Price Monitoring Extn
26th Nov 20204:35 pmRNSPrice Monitoring Extension
11th Nov 20207:00 amRNSFurther re Business Update
30th Oct 20207:00 amRNSHalf-year Report
12th Oct 20207:00 amRNSBusiness Update
28th Sep 20204:41 pmRNSSecond Price Monitoring Extn
28th Sep 20204:36 pmRNSPrice Monitoring Extension
28th Sep 20207:00 amRNSFunding Update
23rd Sep 20207:00 amRNSBusiness Update
14th Sep 20207:00 amRNSJoint Venture Update
5th Aug 202011:00 amRNSTR-1 Notification
5th Aug 20207:00 amRNSUpdated Research Coverage
5th Aug 20207:00 amRNSExercise of Warrants
4th Aug 202011:00 amRNSTR-1 Notification
4th Aug 20208:00 amRNSDirector/PDMR Dealing
3rd Aug 20207:00 amRNSJoint Venture and Funding Update
21st Jul 20207:00 amRNSCompany Secretary Change
30th Jun 20207:00 amRNSAnnual Report 2019
26th Jun 20207:00 amRNSFurther Re Exercise of Warrants / Issue of Equity
18th Jun 20207:00 amRNSExercise of Warrants
26th May 20207:00 amRNSFunding Update
19th May 20207:00 amRNSInitiation Of Research
20th Apr 20207:00 amRNSFurther re: Funding Updates
1st Apr 20207:00 amRNSDirector/PDMR Shareholding
27th Mar 20204:42 pmRNSSecond Price Monitoring Extn
27th Mar 20204:37 pmRNSPrice Monitoring Extension
26th Mar 20207:00 amRNSAgreement
18th Mar 20202:06 pmRNSSecond Price Monitoring Extn
18th Mar 20202:01 pmRNSPrice Monitoring Extension
9th Mar 202011:06 amRNSSecond Price Monitoring Extn
9th Mar 202011:00 amRNSPrice Monitoring Extension
21st Jan 20207:00 amRNSDirector/PDMR Dealing
8th Jan 20205:00 pmRNSHolding(s) in Company
8th Jan 20207:00 amRNSAGM Results
19th Dec 20197:00 amRNSNotice of AGM
17th Dec 20197:00 amRNSKochang Permit Approval
8th Nov 20197:00 amRNSGubong Permit Received
25th Sep 20194:40 pmRNSSecond Price Monitoring Extn
25th Sep 20194:35 pmRNSPrice Monitoring Extension
24th Sep 20197:00 amRNSGubong Permit Approval Update
10th Sep 20197:00 amRNSGubong Permit Approval
9th Jul 20197:00 amRNSDirector Dealing
4th Jul 20197:00 amRNSOperational and Permitting Update
21st Jun 20197:00 amRNSDirector Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.